Skip to content

Clinical trials

Phase 2 alpha 1-Antitrypsin Deficiency trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Phase: Phase 2 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20103
20123
20142
20161
20172
20182
20193
20202
20212
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Withdrawn4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grifols Therapeutics LLC4
Arrowhead Pharmaceuticals3
Vertex Pharmaceuticals Incorporated3
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2
Sanofi2
Beacon Therapeutics1
Columbia University1
Gerard Turino1
Kamada, Ltd.1
Mereo BioPharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency25
Emphysema7
Pulmonary Disease, Chronic Obstructive4
Diabetes Mellitus, Type 12
Liver Diseases2
Lung Diseases2
Cystic Fibrosis1
Diabetes Mellitus1
Liver Cirrhosis1

Trials

Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.